Drug
Myobloc Low Dose
Myobloc Low Dose: highest development phase Phase 3, developed by Supernus Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| MYOBLOC Low Dose NCT05097079 | Phase 3 | Sialorrhea |
Latest
No recent events.
Follow Myobloc Low Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.